Fears grow over Comstock Act, Justices Thomas, Alito: Abortion rights supporters are sounding the alarm that conservative Supreme Court justices want to use a ...
thehill.com/policy/healthcare/4560476-fears-grow-over-comstock-act-justices-thomas-alito/
Quick Glance: The Significance of the Supreme Court Mifepristone Case
- On June 24, 2022, the constitutional jurisprudence on abortions was overturned by the Supreme Court.
- A pivotal aspect in the dispute FDA v. Alliance for Hippocratic Medicine revolves around making access to medication abortions more challenging.
- The decision could impact not only abortion access but also have implications for miscarriage treatment.
- There are also repercussions for the entire country, voters' preferences in blue states, and state sovereignty.
FDA OKs New Treatment to Prevent COVID in High-Risk People: A new antibody treatment has been approved to help prevent COVID-19, and it will be available in a ...
webmd.com/covid/news/20240326/fda-oks-new-treatment-to-prevent-covid-high-risk-people
Quick Glance: FDA Grants Approval for New Treatment to Prevent COVID in High-Risk Individuals
- A newly approved antibody therapy aims to prevent COVID-19 in individuals who are particularly vulnerable.
- Known as Pemgarda, the monoclonal antibody inhibits the virus from binding to human cells and is administered intravenously.
- Close monitoring is required post-antibody treatment due to severe allergic reactions experienced by some individuals.
- Studies indicate that individuals with weakened immune systems continue to face an increased risk of severe COVID outcomes despite multiple COVID vaccinations.
FDA Opens the Door to Clinical Use of LSD: Studies show benefits for people with high anxiety, depression, and PTSD, but there are questions about how these ...
webmd.com/mental-health/news/20240326/fda-opens-the-door-clinical-use-lsd
F.D.A. Authorizes a New Covid Drug to Protect High-Risk People: Pemgarda, available in the coming weeks, is intended for immunocompromised people who are ...
nytimes.com/2024/03/25/well/fda-covid-medicine-immunocompromised.html
FDA renews proposed ban on electrical stimulation devices: The US Food and Drug Administration is again proposing a ban on electrical stimulation devices used to ...
cnn.com/2024/03/25/health/fda-ban-electrical-stimulation-devices/
Elon Musk Takes Ketamine to Help Treat Depression: Does It Work?: In a recent interview, Elon Musk revealed he takes ketamine to help boost his mental health and ...
healthline.com/health-news/elon-musk-ketamine-depression-treatment
US FDA approves Merck's therapy for rare lung condition: The U.S. Food and Drug Administration on Tuesday approved Merck's treatment for adults with high blood ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-mercks-blood-pressure-therapy-2024-03-26/
The U.S. FDA has approved privately held Italfarmaco Group's drug to treat Duchenne muscular dystrophy (DMD), an inherited muscle-wasting disorder ... Show more
FDA settles lawsuit over ivermectin content that doctors claimed harmed their practice
cnn.com/2024/03/27/health/fda-ivermectin-lawsuit/
Paid articlePaid
US FDA approves first drug for fatty liver disease NASH: The U.S. FDA has approved Madrigal Pharmaceuticals' drug for a fatty liver disease known as ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-first-drug-fatty-liver-disease-nash-2024-03-14/
Quick Glance: First Drug Approval for Fatty Liver Disease NASH by US FDA
- The US FDA has approved Madrigal Pharmaceuticals' drug for the fatty liver disease NASH.
- NASH, now known as metabolic dysfunction-associated steatohepatitis (MASH), affects about 1.5 million Americans.
- The drug will be available in April and is seen as a pivotal moment for patients.
- Other companies are also conducting trials of their drugs for NASH to meet the much-needed treatment.
US FDA grants full approval to AbbVie's ovarian cancer therapy: The U.S. Food and Drug Administration said on Friday it had granted traditional approval for ...
reut.rs/496Piyi
Wegovy is now covered by Medicare, but not for weight loss | Here & Now: Wegovy will be covered to prevent heart problems in people with obesity and heart ...
wbur.org/hereandnow/2024/03/26/wegovy-medicare-weight-loss
Seelos Therapeutics' ALS treatment fails mid-stage study: Seelos Therapeutics' experimental ALS drug did not meet the main goal of a mid-stage trial ...
reuters.com/business/healthcare-pharmaceuticals/seelos-says-als-treatment-fails-mid-stage-study-2024-03-19/
The FDA embraces the use of biomarkers and surrogate endpoints in its most recent guidance on developing therapeutics for early Alzheimer’s disease. www.medscape.com/viewarticle/fda-issues-new-guidance-early-alzheimers-drug-development-2024a100052v
Hiltzik: The FDA and a bogus COVID treatment : Three right-wing doctors said the FDA's advice against taking ivermectin for COVID infringed on their rights ...
latimes.com/business/story/2024-03-26/column-the-fda-shoots-itself-in-the-foot-by-settling-a-dumb-lawsuit-over-ivermectin
FDA authorizes drug to boost COVID protection for immunocompromised patients: It will offer added protection to high-risk patients who may have weaker responses ...
axios.com/2024/03/25/covid-antibody-fda
Medicare plans can cover Wegovy for patients with heart conditions: The federal government said that its prescription drug insurance for seniors will cover the ...
washingtonpost.com/business/2024/03/21/wegovy-medicare-part-d/
US FDA approves BeiGene's esophageal cancer therapy: The U.S. Food and Drug Administration said it has approved BeiGene's drug to treat a type of advanced ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-beigenes-esophageal-cancer-therapy-2024-03-14/
Medicare spending on Ozempic and similar diabetes drugs soars, study finds, and it could end up costing seniors
cnn.com/2024/03/26/health/medicare-ozempic-diabetes-drugs-spending/
Regeneron's blood cancer therapy faces setback as FDA raises trial concerns: Regeneron Pharmaceuticals said on Monday the U.S. FDA has declined approval for its ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-declines-approve-regenerons-blood-cancer-therapy-2024-03-25/
US FDA panel votes in favor of expanded use of Bristol Myers' CAR-T therapy: Advisers to the U.S. Food and Drug Administration on Friday voted in favor of ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-panel-votes-favor-expanded-use-bristol-myers-car-t-therapy-2024-03-15/
U.S. abortions reach recent high, with record number done via medication: The increase comes as the U.S. Supreme Court is considering whether to limit access to ...
washingtonpost.com/politics/2024/03/19/abortion-medication-mifepristone-63-percent/
How do biosimilars compare to reference products and generic drugs? Listen to our expert faculty to learn more. ➡️ www.medscape.org/viewarticle/1000238 🌐 Developed in partnership with U.S ...
Becton Dickinson ramps up syringe production in US amid China quality concerns: Becton Dickinson said on Thursday it has increased production of medical syringes ...
reuters.com/business/healthcare-pharmaceuticals/becton-dickinson-increase-domestic-production-syringes-2024-03-21/
Lilly weight-loss drug Zepbound new US prescriptions surpass Wegovy for first time
reuters.com/business/healthcare-pharmaceuticals/lilly-weight-loss-drug-zepbound-new-us-prescriptions-surpass-wegovy-first-time-2024-03-15/
Spotlight On: Major Depressive Disorder: The most important news, trends, and treatments that affect people with major depression.
webmd.com/depression/features/cm/mdd-spotlight-on
Madrigal's drug wins first US approval for fatty liver disease NASH as rivals circle
reuters.com/business/healthcare-pharmaceuticals/madrigals-drug-wins-first-us-approval-fatty-liver-disease-nash-rivals-circle-2024-03-14/
Viatris generic hypertension drug does not violate J&J patents, US court says: Generic drugmaker Viatris has convinced a federal judge in West Virginia that its ...
reuters.com/legal/litigation/viatris-generic-hypertension-drug-does-not-violate-jj-patents-us-court-says-2024-03-15/
FDA advisory panel recommends revision to flu vaccine: VRBPAC on Tuesday recommended that the agency drop the Yamagata part of the flu vaccine.
axios.com/2024/03/06/flu-vaccine-modified-virus
The mifepristone case: abortion and the US supreme court meet again: On Tuesday the justices will hear oral arguments on a rightwing effort to roll back access ...
theguardian.com/world/2023/aug/17/what-abortion-pill-supreme-court-case-access-mifepristone
FDA approved a lifesaving therapy for children with a rare genetic disease. It might become the world’s most expensive drug
cnn.com/2024/03/19/health/gene-therapy-orchard-mld/
Paid articlePaid
How Telehealth Widens Access to the Abortion Pill: Without telehealth, one in seven women would have to drive over 200 miles to the nearest provider
wsj.com/us-news/supreme-court-abortion-pill-ruling-access-9a5597e3
Wegovy Approved By FDA to Reduce Heart Attack Risk: The F.D.A. has approved a new use for heart health that will fuel even more demand for the drug.
nytimes.com/2024/03/11/well/live/wegovy-ozempic-heart-risk.html
Mifepristone access is coming before the US Supreme Court. How safe is this abortion pill?
apnews.com/article/mifepristone-abortion-pill-supreme-court-1d2221251197a391c9bca833918e4554
Medicare Gets Big Change: Wegovy, a weight-loss drug, has been approved for coverage for patients on Medicare who have a history of heart disease.
newsweek.com/wegovy-approved-medicare-insurance-heart-disease-1883177
In a pandemic milestone, the NIH ends guidance on COVID treatment: The National Institutes of Health is sunsetting its influential COVID-19 treatment guidelines ...
npr.org/sections/health-shots/2024/03/19/1239276507/nih-covid-treatment-guidelines
Military flags risks in drug supply chain: Just a quarter of essential medicines are sourced in the U.S., a Pentagon review found.
axios.com/2024/03/20/military-drug-shortages
US FDA staff flags concerns about Geron's anemia treatment: The U.S. health regulator's staff on Tuesday flagged concerns that the late-stage trial data on ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-staff-flags-concerns-about-gerons-anemia-treatment-2024-03-12/
Pressure-Relief Eye Tech Advances Toward Approval: FDA panel’s green light on glaucoma wearable device offers hope in sight
spectrum.ieee.org/glaucoma-treatment-device
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
cnbc.com/2024/03/19/healthy-returns-first-nash-liver-disease-drug-is-here-more-coming.html
Growing market for glucose monitoring fueled by nondiabetics: Weight-loss drugs are helping fuel broader interest in the devices, even as many doctors have mixed ...
axios.com/2024/03/19/glucose-monitoring-blood-sugar-diabetes
Commentary: If feds won’t do it, SC lawmakers must protect kids from Chinese vapes
postandcourier.com/opinion/commentary/vaping-china-sc-legislature-biden/article_ee42f22a-dfc3-11ee-ae0c-432ae910fed0.html
The Ozempic Revolution Is Stuck: Millions more Americans are now eligible for obesity drugs. But the injections remain maddeningly hard to find.
theatlantic.com/health/archive/2024/03/ozempic-revolution-stuck/677736/
Zepbound Shortage: Eli Lilly Weight-Loss Drug Faces Backorders: Eli Lilly’s new weight-loss shot is on backorder across the US, even as the FDA says there’s ...
bloomberg.com/news/articles/2024-03-26/zepbound-shortage-eli-lilly-weight-loss-drug-faces-backorders
LSD, Ecstasy Lure Traders Betting on ‘Psychedelic Renaissance’: For years, investors that poured money into psychedelic stocks have wagered that their breakout ...
bloomberg.com/news/articles/2024-03-28/lsd-ecstasy-lure-traders-betting-on-psychedelic-renaissance
Women Can Now Access Birth Control Without a Prescription in New York: A new ruling allows pharmacists to dispense the drug—even for out-of-staters.
harpersbazaar.com/culture/politics/a60254800/women-access-birth-control-without-prescription-new-york/
Paid articlePaid
Diabetes Play Tops Buy Point In Rally To New Highs: Dexcom stock: The diabetes play rallied to new highs this week, topping a new buy point in the wake of the ...
investors.com/stock-lists/sector-leaders/dexcom-dxcm-stock/
Zydus Lifesciences gets 4 observations from USFDA for Gujarat plant: Zydus Lifesciences on Wednesday said the US health regulator has issued a Form-483 with four ...
business-standard.com/companies/news/zydus-lifesciences-gets-4-observations-from-usfda-for-gujarat-plant-124032700780_1.html
India pharma quality lapses force U.S. to look to China for vital drugs: In the final weeks of 2022, a small team of inspectors from the U.S ...
asia.nikkei.com/Spotlight/Special-Reports/India-pharma-quality-lapses-force-U.S.-to-look-to-China-for-vital-drugs
FACT CHECK: Unregistered anti-itch not endorsed by Doc Liza Ong: The Philippine Food and Drug Administration has not approved the product Arturo Doctor Zu ...
rappler.com/newsbreak/fact-check/unregistered-anti-itch-not-endorsed-doc-liza-ong/
How healthcare AI is regulated by the FDA, HHS, state laws: Widespread oversight of artificial intelligence in healthcare is a work in progress but there are ...
modernhealthcare.com/digital-health/healthcare-ai-regulation-fda-hhs
Paid articlePaid
USFDA gives nod to nonsteroidal treatment for Duchenne Muscular Dystrophy: The FDA granted this application priority review and fast track designation ...
financialexpress.com/healthcare/pharma-healthcare/fda-gives-nod-to-nonsteroidal-treatment-for-duchenne-muscular-dystrophy/3435687/
The FDA granted this application priority review and fast track designation. It also received orphan drug and rare pediatric disease designations.
Radiopharma Space Heats Up As Biotech Rockets 97% on $2 Billion Deal: AstraZeneca said Tuesday is would acquire Fusion Pharmaceuticals for $2 billion upfront ...
investors.com/news/technology/fusion-pharmaceuticals-astrazeneca-acquisition-biotech-stock/
NAFDAC raids fake water factory in Rivers, arrests one: The agency said the discovery on Friday morning followed a tip off from some well-meaning members of the ...
punchng.com/nafdac-raids-fake-water-factory-in-rivers-arrests-one/
Lenmeldy Sparks Controversy as World's Most Expensive Medicine, Debating the $4.25 Million Price Tag
techtimes.com/articles/302871/20240322/lenmeldy-sparks-controversy-worlds-most-expensive-medicine-debating-4-25-million-price-tag.htm
First over-the-counter birth control pill now for sale online: Opill, an over-the-counter birth control pill, goes on sale online today. The pill is expected to ...
npr.org/sections/health-shots/2024/03/04/1235404522/opill-over-counter-birth-control-pill-contraceptive-shop
Oprah’s Ozempic Special Was a Missed Opportunity for Obesity: The Queen of All Media is trying to reset our national conversation about body size ...
bloomberg.com/opinion/articles/2024-03-19/oprah-s-ozempic-special-was-a-missed-opportunity-for-obesity
Paid articlePaid
Opinion: Menthol cigarettes are menace to Black community: As executive director for the Center for Black Health & Equity, I’ve witnessed the devastating health ...
ajc.com/opinion/opinion-menthol-cigarettes-are-menace-to-black-community/CK5T5YSZBJFXTGS33ZA3O6EB7Y/
Wegovy (NOVOB DC) for Heart Disease Now Covered by Medicare Part D Plans: Medicare prescription drug programs can now cover Novo Nordisk A/S’s blockbuster ...
bloomberg.com/news/articles/2024-03-21/medicare-drug-plans-can-now-cover-wegovy-for-heart-disease
Paid articlePaid
Dozens sue saying Ozempic, other weight loss and diabetes drugs cause harmful side effects
usatoday.com/story/news/health/2024/03/21/lawsuits-ozempic-wegovy-weight-loss-drugs-diabetes-harmful/72947158007/
Novo Nordisk’s weight-loss wonder drugs could also help with dementia, liver disease, and more
fastcompany.com/91042014/novo-nordisk-most-innovative-companies-2024
Obey House resolution, lift sachet alcohol ban, Reps tell NAFDAC: The House of Representatives, on Wednesday, called on the National Agency for Food and Drug ...
punchng.com/obey-house-resolution-lift-sachet-alcohol-ban-reps-tell-nafdac/
Trader Joe's is recalling its second food product this month — make sure you don't eat it
thestreet.com/retail/trader-joes-is-recalling-its-second-food-product-this-month
FACT CHECK: Height Maxx Nutri-C Tall is not FDA approved: The Philippine FDA issued an advisory in August 2023 urging the public to avoid purchasing and ...
rappler.com/newsbreak/fact-check/height-maxx-nutri-c-tall-not-fda-approved/
Companies Can Claim Yogurt Reduces Diabetes Risk, FDA Says: Yogurt manufacturers can now claim that eating yogurt reduces a person’s risk of type 2 diabetes ...
webmd.com/diabetes/news/20240304/companies-can-claim-yogurt-reduces-diabetes-risk-fda-says
Quick Glance: Can Yogurt Really Reduce the Risk of Diabetes?
- The FDA now allows certain health claims regarding yogurt consumption and the reduction of the risk of type 2 diabetes.
- Qualified health claims must meet specific criteria and should not confuse consumers.
- While yogurt offers many health benefits, it is crucial to make careful choices to maintain stable blood sugar levels.
- In addition to yogurt, there are other foods that can help reduce the risk of type 2 diabetes, such as berries, beans, and avocados.
New weight loss pill amycretin more effective than semaglutide in early trial: Novo Noridisk has announced the results of a phase 1 clinical trial testing their ...
medicalnewstoday.com/articles/new-weight-loss-pill-amycretin-more-effective-than-semaglutide-in-early-trial
Can Eating Yogurt Really Reduce Your Risk of Diabetes?: The FDA has approved a qualified health claim that yogurt—specifically eating two cups or three servings ...
health.com/yogurt-reduce-diabetes-risk-8606635
When diet and exercise aren’t enough, new drug can treat fatty liver disease, says FDA
cleveland.com/news/2024/03/when-diet-and-exercise-arent-enough-new-drug-can-treat-fatty-liver-disease-says-fda.html
Paid articlePaid
How diabetes drug metformin can suppress hunger and help with weight loss: Researchers say the diabetes drug metformin can help people lose weight by increasing ...
medicalnewstoday.com/articles/how-diabetes-drug-metformin-can-suppress-hunger-and-help-with-weight-loss
How Medicare can start covering a popular weight-loss drug for more people: The recent approval of Wegovy for heart risks could greatly expand access ...
axios.com/2024/03/14/medicare-weight-loss-drugs-ozempic-wegovy-coverage
Proscia’s $46M Series C propels AI-driven pathology into the mainstream: Proscia raises $9M in Series C extension and secures FDA clearance to accelerate the ...
venturebeat.com/ai/proscias-46m-series-c-propels-ai-driven-pathology-into-the-mainstream/
US FDA staff raise concerns over data from J&J, Bristol's CAR-T therapies: The U.S. Food and Drug Administration's staff on Wednesday raised concerns that it was ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-staff-flag-safety-concerns-jj-bristols-car-t-therapies-2024-03-13/
Fake Ozempic Shows Dark Side of Weight-Loss Frenzy: Inside the UK task force tackling potentially deadly obesity drug counterfeits
bloomberg.com/news/articles/2024-03-13/fake-ozempic-shows-dark-side-of-weight-loss-frenzy
How much higher can Novo Nordisk shares go?: Novo Nordisk's remarkable ascent, driven by its revolutionary weight-loss drug Wegovy ...
euronews.com/business/2024/03/13/how-high-can-novo-nordisk-shares-go
Wegovy’s newly verified heart benefits under review by Medicare: The US federal health insurance, Medicare may soon be required to cover the blockbuster ...
dailymaverick.co.za/article/2024-03-12-wegovys-newly-verified-heart-benefits-under-review-by-medicare/
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics